Neither Long-Term Statin Use nor Atherosclerotic Disease Is Associated With Risk of Colorectal Cancer

详细信息    查看全文

• 作者：Douglas J. Robertson^?/sup> ; ^&Dagger ; ; ^{douglas.robertson@va.gov} ; Anders Hammerich Riis^&sect ; ; Sø ; ren Friis^?/sup> ; Lars Pedersen^&sect ; ; John A. Baron^¶ ; ; ^# ; Henrik Toft Sø ; rensen^&sect ;
• 关键词：ICD ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Colorectal Neoplasms ; Epidemiology ; Myocardial Infarction
• 刊名：Clinical Gastroenterology and Hepatology
• 出版年：2010
• 出版时间：December 2010
• 年：2010
• 卷：8
• 期：12
• 页码：1056-1061
• 全文大小：269 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferencescoding=""UTF-8""?>

class=""h4"">Background & Aims

Statin use has been reported to reduce risk for colorectal cancer (CRC) whereas atherosclerotic disease has been reported to increase risk, but findings have been inconsistent. We aimed to establish the association of statin use and coronary atherosclerosis with CRC.

class=""h4"">Methods

We performed a population-based case control study of patients with a first diagnosis of CRC cancer between January 1, 1991, and December 31, 2008 (n = 9979), using the Danish National Registry of Patients. As many as 10 population controls were matched to each patient using risk set sampling (n = 99,790). Statin use before cancer diagnosis (or control index date) was determined via county prescription databases and evidence of coronary atherosclerosis using International Classification of Diseases codes. We calculated incidence rate ratios using conditional logistic regression, adjusted for multiple covariates.

class=""h4"">Results

Among patients with CRC, statin use was modest (7.7 % ), but 23.5 % of use was long term (? years). Ever use of statins (? prescriptions) slightly reduced CRC risk, compared with relative to never/rare use (incidence rate ratio [IRR] = 0.87, 95 % confidence interval = 0.80?.96). However, long-term use did not affect risk compared with never/rare use (IRR = 0.95, 95 % 0.80?.12). No associations were observed between atherosclerosis, myocardial infarction, or stroke, and CRC incidence.

class=""h4"">Conclusions

Although there is a weak inverse association between ever use of statins and CRC incidence, there was no trend with increasing duration of use, so statins do not appear to reduce CRC risk. We did not confirm the reported association between atherosclerosis and CRC risk.